Bluebird secures up to $175M in debt financing deal

The agreement includes an initial tranche totaling $75 million, and additional capital dependent on bluebird bio hitting certain commercial milestones on the rollout of its FDA-approved gene therapies.

Source: bizjournals.com Health Care:Biotechnology headlines - March 18, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news